Masimo (NASDAQ:MASI), a global leader in medical innovation, has announced a strategic partnership with Google to develop a new reference platform aimed at revolutionizing the Wear OS by Google™ smartwatch ecosystem. This collaboration promises to integrate Masimo's advanced biosensing technologies with Google's Wear OS, offering a streamlined solution for original equipment manufacturers (OEMs) to create high-performance smartwatches.
The new reference platform will leverage Masimo’s cutting-edge expertise in biosensing, which has been honed through decades of pioneering hospital monitoring solutions. By incorporating these technologies into Wear OS smartwatches, OEMs will benefit from a robust, standardized platform that supports the growing demand for sophisticated health and wellness tracking tools. This initiative is set to enhance the accuracy and reliability of data provided by smartwatches, ensuring a seamless integration with Android™ smartphones and delivering a superior user experience.
Joe Kiani, Founder and CEO of Masimo, expressed enthusiasm about the partnership, highlighting the potential of the new reference platform. “We’re excited to partner with Google to develop a reference platform for Wear OS that leverages our expert engineering capabilities,” said Kiani. “Our decades of experience in developing next-generation biosensing technologies and precision components provide a solid foundation for creating a world-class smartwatch reference platform. Our engineers are optimizing every aspect of the smartwatch, from hardware to software, to deliver an exceptional solution for OEMs. We anticipate that this platform will significantly enhance the capabilities of smartwatch manufacturers, much as our hospital monitoring technologies have elevated patient care.”
Bjorn Kilburn, General Manager of Wear OS at Google, echoed this sentiment, emphasizing the benefits for smartwatch makers. “Building quality smartwatches with premium features can be both time-consuming and costly. With Masimo’s reference platform, manufacturers will gain access to state-of-the-art biosensing technology, enabling them to bring Wear OS devices to market more efficiently and at scale. Our collaboration aims to drive innovation across the Wear OS ecosystem, providing users with high-performing and feature-rich devices.”